Intactis Bio develops a bio-artificial neural network that integrates silicon computers with living neurons for large-scale, energy-efficient AI/ML data processing. This proprietary biocomputation platform overcomes the energy limitations currently constraining silicon-based AI computation. The company enables high-performance workloads by deploying scalable biocomputers alongside energy-constrained data centers.
Funding
Funding not disclosed
Founders
Product
Problem
Conventional silicon-based AI/ML computing faces increasing energy limitations, potentially exceeding global electricity output by 2040. This energy ceiling restricts the scalability and advancement of AI/ML models and high-performance computing workloads.
Solution
Intactis Bio is developing a bio-artificial neural network that combines silicon computers and living neurons to provide scalable, ultra-efficient computation. Their biocomputation platform utilizes a proprietary neural tissue and brain-machine interface to perform complex calculations with significantly reduced energy consumption. By co-locating their biocomputer with energy-constrained data centers, Intactis Bio aims to enable AI/ML models and high-performance workloads to overcome power limitations and achieve sustainable biocomputation. The company's scalable bioprocess ensures long-term viability for centimeter-scale neural tissues.
Target Audience
Intactis Bio's primary customers are organizations with energy-constrained data centers, AI/ML developers, and researchers in drug discovery seeking sustainable, high-performance computing solutions.
Features
- Proprietary neural tissue engineered for biocomputation.
- Brain-machine interface for seamless integration of biological and silicon-based computing.
- Scalable bioprocess ensuring long-term tissue viability at clinically relevant scales.
- Low-cost data modeling and analysis services using traditional methods.
- Custom neuromorphic platform for building AI/ML applications.